UPDATED 12.06.2014 09:58

Organised cervical cancer screening programme in Finland in the invitation year 2012. Numbers and percentage distribution of primary screening test results, referrals for further investigations, and histological diagnosis of the cervix uteri. Information registered from 336 municipalities (out of 336).

Screening Screened Referral Histological diagnosis
test     Invasive
carcinoma
Microinvasive
carcinoma
Carcinoma
in situ
Dysplasia
gravis
Dysplasia
moderata
Dysplasia
levis
Other or
normal
  n n % n % n % n % n % n % n % n %
Pap test1 172884 1435 0.83 12 0.01 4 0.00 17 0.01 196 0.11 190 0.11 169 0.10 847 0.49
I 162467 8 0.00 - - - - - - - - - - - - 8 0.00
II 9165 246 0.14 - - - - 2 0.00 5 0.00 9 0.01 28 0.02 202 0.12
III 1129 1075 0.62 5 0.00 2 0.00 8 0.00 151 0.09 168 0.10 132 0.08 609 0.35
IV 100 100 0.06 5 0.00 1 0.00 7 0.00 39 0.02 12 0.01 9 0.01 27 0.02
V 6 6 0.00 2 0.00 1 0.00 - - 1 0.00 1 0.00 - - 1 0.00
Inadequate 16 - - - - - - - - - - - - - - - -
Unknown 1 - - - - - - - - - - - - - - - -
HPV test 11133 152 1.37 1 0.01 1 0.01 2 0.02 18 0.16 18 0.16 10 0.09 102 0.92
Negative1 10360 6 0.05 - - - - - - - - - - - - 6 0.05
Positive2 773 146 1.31 1 0.01 1 0.01 2 0.02 18 0.16 18 0.16 10 0.09 96 0.86
Total 184017 1587 0.86 13 0.01 5 0.00 19 0.01 214 0.12 208 0.11 179 0.10 949 0.52

1 Women with Papanicolaou class I or II or negative HPV test are not referred for further examinations unless repeated cytology or other results are suggestive of cancer.
2 Women whose HPV test is positive are referred for further examinations on the basis of cytology or a repeatedly positive result.